Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Apr 23;58(5):e00187-20.
doi: 10.1128/JCM.00187-20. Print 2020 Apr 23.

Emergence of a Novel Coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2: Biology and Therapeutic Options

Suliman Khan  1   2 , Rabeea Siddique  3   2 , Muhammad Adnan Shereen  4 , Ashaq Ali  5 , Jianbo Liu  6 , Qian Bai  3   2 , Nadia Bashir  4 , Mengzhou Xue  1   2
Affiliations
Review

Emergence of a Novel Coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2: Biology and Therapeutic Options

Suliman Khan et al. J Clin Microbiol. .

Erratum in

Abstract

The new decade of the 21st century (2020) started with the emergence of a novel coronavirus known as SARS-CoV-2 that caused an epidemic of coronavirus disease (COVID-19) in Wuhan, China. It is the third highly pathogenic and transmissible coronavirus after severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) emerged in humans. The source of origin, transmission to humans, and mechanisms associated with the pathogenicity of SARS-CoV-2 are not yet clear, however, its resemblance to SARS-CoV and several other bat coronaviruses was recently confirmed through genome sequencing-related studies. The development of therapeutic strategies is necessary in order to prevent further epidemics and cure infections. In this review, we summarize current information about the emergence, origin, diversity, and epidemiology of three pathogenic coronaviruses with a specific focus on the current outbreak in Wuhan, China. Furthermore, we discuss the clinical features and potential therapeutic options that may be effective against SARS-CoV-2.

Keywords: novel coronavirus; outbreak; therapeutics; transmission.

PubMed Disclaimer

References

    1. Zumla A, Chan JFW, Azhar EI, Hui DSC, Yuen KY. 2016. Coronaviruses—drug discovery and therapeutic options. Nat Rev Drug Discov 15:327–347. doi:10.1038/nrd.2015.37. - DOI - PMC - PubMed
    1. Cui J, Li F, Shi ZL. 2019. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol 17:181–192. doi:10.1038/s41579-018-0118-9. - DOI - PMC - PubMed
    1. Zhong NS, Zheng BJ, Li YM, Poon LLM, Xie ZH, Chan KH, Li PH, Tan SY, Chang Q, Xie JP. 2003. Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People’s Republic of China, in February, 2003. Lancet 362:1353–1358. doi:10.1016/S0140-6736(03)14630-2. - DOI - PMC - PubMed
    1. Bawazir A, Al-Mazroo E, Jradi H, Ahmed A, Badri M. 2018. MERS-CoV infection: mind the public knowledge gap. J Infect Public Health 11:89–93. doi:10.1016/j.jiph.2017.05.003. - DOI - PMC - PubMed
    1. Zaki AM, Van Boheemen S, Bestebroer TM, Osterhaus A, Fouchier R. 2012. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 367:1814–1820. doi:10.1056/NEJMoa1211721. - DOI - PubMed

Publication types

MeSH terms